HUMLEBAEK, Denmark, Nov. 6, 2009 (GLOBE NEWSWIRE) -- Coloplast's full year
announcement reveals a vast increase in profitability. In 2008/09, the company
realised EBIT of DKK 1,395m equal to an EBIT margin of 16% against 12% last
year. In Q4, 2008/09 profit was DKK 406m equal to an EBIT margin of 18%.
"We have become more efficient and more profitable during the year, so I am very
pleased with the results, especially the Q4 is very strong," says Lars
Rasmussen, President & CEO.
In line with Coloplast's expectations, the 2008/09 organic revenue growth was
6%, which is also the general market growth. Q4 growth was 7%.
"I'm pleased with the strong increase in profitability, but we still want higher
growth. Now that we have profit under control we have a solid basis for
fulfilling that ambition," says Lars Rasmussen.
In 2009/10 Coloplast expects an organic revenue growth of 6-7%. Based on
constant exchange rates, revenue growth in DKK is expected to be 4-5%. Coloplast
expects an EBIT margin in constant exchange rates of 17-18% and in DKK of
16-17%.
-0-
CONTACT: Coloplast A/S
PRESS CONTACT
Morten Sorensen, Media Relations Manager, Corporate
Communications
+45 4911 2632
dkmoso@coloplast.com
INVESTOR RELATIONS
Ian S. E. Christensen, Head of Investor Relations
+45 4911 1301
dkisec@coloplast.com
